Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of different forms of tranexamic acid in the treatment of hemoptysis
IRCT20211026052880N1Phase 3Recruiting
- Sponsor
- IGES Institut
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of tranexamic acid in hemoptysis, sponsored by IGES Institut. Started Aug 2025; status: recruiting.
02
Drugs
tranexamic acid
03
Conditions
hemoptysis
Beyond the preview
Go deeper on IRCT20211026052880N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20211026052880N1.